The Size of the Middle East & Africa Organ Preservation Market was valued at USD 17.33 million in 2022 and estimated to grow at a CAGR of 3.6%, to reach USD 20.68 million by 2027 during the forecast period 2022 to 2027.
Organ preservation's primary vital drivers are likely to be various technological developments and advancements throughout the organ transplantation and preservation industry. In addition, due to the increasing incidences of organ failure, the rapid rise of the elderly population, and many regional authorities are enacting favorable legislation.
The practice of keeping and maintaining organs donated for transplantation is known as organ preservation. In addition, they coordinate activities and public awareness campaigns to increase organ donors and transplant procedures throughout the region to fuel market growth.
With the growth in technological breakthroughs and improvements, this method involves cleaning the organ with a specific preservation solution depending on its demands and preserving it using various procedures necessary by the organ.
Also, due to the increase in the growing prevalence of chronic illnesses like chronic obstructive pulmonary diseases, disorders needing lung transplantation, and other target illnesses are driving the market growth. In addition, the increase in the growing elderly population is giving rise to the number of organ transplants and organ donors, and increasing measures and government initiatives to encourage organ donation are all driving the expansion of the organ preservation industry.
Market expansion is likely to be limited to some extent by the high cost of organ transplantation and religious concerns in particular countries. In addition, the large-scale costs associated with organ transplantation procedures limit procedure consumers to a smaller consumer base.
The lack of suitable donors and alternative modes of organ transplantation available in the market affects market growth. Also, limiting reimbursements for donating and transplanting organs can hurt the development of the organ preservation market.
This research report on the Middle East & Africa Organ Preservation Market has been segmented and sub-segmented into the following categories.
By Preservation Solution:
By Transportation Technique:
By Organ Type:
By Country:
The MEA market is expected to show significant growth in the market in the forecast period owing to the increase in the senior population in the region with the rise in the incidences of multi-organ failure with the increasing number of organ transplantation procedures in the market.
UAE organ preservation market and Saudi Arabia organ preservation market are expected to increase market growth in the forecasted years by developing new advancements in technology with an increase in government and non-government initiatives to encourage and spread awareness among people about donating organs. In addition, due to the rise in the prevalence of chronic diseases like cardiac vascular diseases, ischemic heart diseases in both regions are increasing the demand in the market.
South Africa organ preservation market is projected to witness a promising share in the organ preservation market in the following years. The market is estimated to be driven by the increase in chronic diseases. Also, kidney failure is expected to elevate the market growth of the organ preservation market as South Africa has over 11,718 prevalence rates as per the 100,000 population.
KEY MARKET PARTICIPANTS
Key Market Companies leading the Middle East & Africa Organ Preservation Market Profiled in the Report are Essential Pharmaceuticals (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), and Waters Medical Systems LLC (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technique
5.1.1 Introduction
5.1.2 Static Cold Storage (SCS) Technique
5.1.3 Hypothermic Machine Perfusion
5.1.4 Normothermic Machine Perfusion
5.1.5 Y-o-Y Growth Analysis, By Technique
5.1.6 Market Attractiveness Analysis, By Technique
5.1.7 Market Share Analysis, By Technique
5.2 Preservation Technique
5.2.1 Introduction
5.2.2 University of Wisconsin Solution (UW Solution)
5.2.3 Custodiol HTK
5.2.4 Perfadex
5.2.5 Other Preservation Solutions
5.2.6 Y-o-Y Growth Analysis, By Preservation Technique
5.2.7 Market Attractiveness Analysis, By Preservation Technique
5.2.8 Market Share Analysis, By Preservation Technique
5.3 Organ Type
5.3.1 Introduction
5.3.2 Kidneys
5.3.3 Liver
5.3.4 Lung
5.3.5 Heart
5.3.6 Other Organs (Pancreas, Intestine)
5.3.7 Y-o-Y Growth Analysis, By Organ Type
5.3.8 Market Attractiveness Analysis, By Organ Type
5.3.9 Market Share Analysis, By Organ Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technique
6.1.3.3 By Preservation Technique
6.1.3.4 By Organ Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technique
6.1.4.3 By Preservation Technique
6.1.4.4 By Organ Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technique
6.1.5.3 By Preservation Technique
6.1.5.4 By Organ Type
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Waters Medical Systems LLC [Institut Georges Lopez (IGL]
8.1.1 Overview
8.1.2 Technique Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bridge to Life Limited
8.3 Organox Limited
8.4 Transmedics, Inc.
8.5 Xvivo Perfusion AB
8.6 Preservation Solutions, Inc.
8.7 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
8.8 Essential Pharmaceuticals, LLC
8.9 Dr. Franz Kohler Chemie GmbH
8.10 21st Century Medicine Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
